Refractory Malignancy
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors (NCT00613145) | SCRI Development Innovations, LLC | 2008-02-01 |
| Phase I Study of Patupilone and RAD001 (NCT00496600) | University of Medicine and Dentistry of New Jersey | 2007-07-01 |
| PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies (NCT00611793) | SCRI Development Innovations, LLC | 2004-10-01 |
| Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors (NCT00611689) | SCRI Development Innovations, LLC | 2004-07-01 |
Track Refractory Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.